IceCure Medical ICCM Cash Flow Statement (2020-2026)

NASDAQ ICCM
$2.11 -0.10 (-4.52%)
At close: Sep 9, 2026 · 4:00 PM EDT
Reported Financials

IceCure Medical Quarterly Cash Flow Statement

Periods 24 quarters
Latest Jun 2026

IceCure Medical reported cash from operations of -$3.88M and free cash flow of -$3.87M for the quarter ended Jun 2026, down 37.9% year over year. This cash flow statement covers 24 quarters of results from Sep 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-10.58M16.63M-4.45M-4.52M-4.06M30.00M-3.77M-3.89M-4.00M26.31M-3.61M-3.08M-4.15M-4.48M-3.59M-3.36M-3.86M-4.25M-4.27M-4.50M
Share-based CompensationStock Comp.
0.07M0.06M0.45M0.47M0.51M0.36M0.32M0.33M0.30M0.24M0.17M0.24M0.22M0.12M0.17M0.81M0.27M0.18M0.12M
Cash from OperationsCash from Ops.
-3.15M-5.89M-3.06M-3.79M-3.32M-4.13M-2.94M-3.97M-3.34M-2.30M-2.85M-2.36M-3.15M-4.20M-4.04M-2.81M-2.71M-5.02M-4.27M-3.88M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
-0.74M0.12M0.03M0.07M0.07M0.08M0.05M0.01M0.06M0.06M0.07M0.06M0.07M0.07M0.10M0.07M0.08M0.08M0.09M0.09M
Depreciation & Amortization (CF)Dep. & Amort.
0.04M0.04M0.05M0.05M0.07M0.07M0.08M0.08M0.08M0.08M0.09M0.08M0.08M0.08M0.09M0.06M0.07M0.07M0.07M0.07M
Change in Working Capital
Change in ReceivablesChange Receivables
-0.37M0.01M0.26M-0.01M0.12M-0.07M0.03M0.01M0.01M-0.05M-0.17M0.18M-0.08M-0.08M0.18M0.02M-0.23M0.06M-0.14M
Change in InventoryChange Inventory
-0.31M-0.18M-0.37M-0.33M-0.05M-0.16M-0.07M0.18M0.10M0.37M0.16M0.14M-0.01M-0.01M-0.05M-0.29M-0.38M0.09M-0.02M0.10M
Change in Account PayablesChange Payables
0.04M0.04M-0.21M0.27M-0.34M0.11M-0.03M-0.03M0.48M-0.63M0.16M0.04M0.55M-0.02M-0.28M0.21M-0.01M-0.29M0.12M0.65M
Change in Accured ExpensesChange Accured Exp.
0.27M-0.58M1.13M-0.85M0.28M-0.01M0.19M-0.65M-0.09M0.38M0.06M0.32M-0.05M-0.26M-0.34M0.05M0.64M-0.48M-0.31M0.11M
Investing Activities
Capital ExpendituresCapex
-0.11M-0.18M-0.14M-0.35M-0.30M-0.10M-0.25M-0.07M-0.08M-0.08M-0.03M-0.01M-0.03M-0.01M-0.01M-0.02M-0.00M-0.01M-0.05M-0.01M
Change in Acquisitions & DivestmentsChange Acquisitions
2.50M-14.87M16.27M7.30M-9.20M0.53M0.54M0.84M10.00M
Cash from Investing ActivitiesCash from Investing
-0.11M-0.18M-0.14M-4.63M2.20M1.68M-15.12M1.50M4.22M8.71M0.49M-0.84M0.81M-0.01M-0.01M-0.02M-5.00M5.00M-0.05M-0.01M
Financing Activities
Other financing activitiesOther financing
0.01M0.27M0.07M-2.35M15.25M
Cash from Financing ActivitiesCash from Financing
0.01M16.24M13.58M0.07M2.84M1.89M3.36M1.10M2.56M2.08M7.47M3.72M3.54M7.78M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
0.11M1.81M1.16M0.02M0.06M
Net Equity Issued and RepurchasedNet Equity Issued
1.38M2.84M1.89M3.36M1.10M2.56M2.85M9.18M3.54M
Additional items
Exchange Rate EffectFX Effect
0.12M-0.03M0.06M-0.60M1.02M-0.83M0.01M-0.11M0.30M-0.18M0.04M-0.08M0.01M-0.01M-0.04M0.09M-0.17M0.23M0.00M0.02M
Change in Cash
-3.25M10.17M-3.20M-8.41M-1.12M11.12M-18.06M-2.47M0.90M6.48M0.48M-1.32M1.01M-3.10M-1.48M-0.75M-0.24M3.70M-0.79M3.90M
Beginning Cash Balance
3.50M25.62M25.62M23.66M23.66M10.53M10.53M7.56M
Free Cash FlowFCF
-3.04M-5.72M-2.92M-3.44M-3.02M-4.03M-2.69M-3.90M-3.26M-2.22M-2.82M-2.36M-3.12M-4.19M-4.03M-2.79M-2.70M-5.01M-4.22M-3.87M
Net Cash FlowNCF
-3.25M10.17M-3.20M-8.41M-1.12M11.12M-18.06M-2.47M0.89M6.48M0.48M-1.32M1.01M-3.10M-1.48M-0.75M-0.24M3.70M-0.79M3.90M